Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders

被引：21
|
作者：
Borja, Austin J. [1 ,2 ]
Hancin, Emily C. [1 ,3 ]
Zhang, Vincent [1 ]
Revheim, Mona-Elisabeth [1 ,4 ,5 ]
Alavi, Abass [1 ]
机构：
[1] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[4] Oslo Univ Hosp, Div Radiol & Nucl Med, Oslo, Norway
[5] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 11期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; BRAIN METABOLISM; COGNITIVE IMPAIRMENT; RISK-ASSESSMENT; A-BETA; STROKE; CALCIFICATION; NEUROPATHOLOGY;
D O I：
10.1007/s00259-020-04697-y
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2493 / 2498
页数：6
相关论文
共 50 条
  • [41] Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage
    Anna M. Pietroboni
    Annalisa Colombi
    Tiziana Carandini
    Luca Sacchi
    Chiara Fenoglio
    Giorgio Marotta
    Andrea Arighi
    Milena A. De Riz
    Giorgio G. Fumagalli
    Massimo Castellani
    Marco Bozzali
    Elio Scarpini
    Daniela Galimberti
    Alzheimer's Research & Therapy, 14
  • [42] Utility of PET/CT for assessing equivocal PET lesions in oncology - Initial experience.
    Yeung, HW
    Schoder, H
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 32P - 32P
  • [43] Differential Diagnosis of Neurodegenerative Dementias Using Metabolic Phenotypes on F-18 FDG PET/CT
    Tripathi, Madhavi
    Tripathi, Manjari
    Damle, Nishikant
    Kushwaha, Suman
    Jaimini, Abhinav
    D'Souza, Maria M.
    Sharma, Rajnish
    Saw, Sanjiv
    Mondal, Anupam
    NEURORADIOLOGY JOURNAL, 2014, 27 (01): : 13 - 21
  • [44] Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage
    Pietroboni, Anna M.
    Colombi, Annalisa
    Carandini, Tiziana
    Sacchi, Luca
    Fenoglio, Chiara
    Marotta, Giorgio
    Arighi, Andrea
    De Riz, Milena A.
    Fumagalli, Giorgio G.
    Castellani, Massimo
    Bozzali, Marco
    Scarpini, Elio
    Galimberti, Daniela
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [45] Potential role of platelet glycoprotein IIb/IIIa antagonists in cerebrovascular disorders
    Mousa, SA
    CNS DRUGS, 2000, 13 (03) : 155 - 160
  • [46] Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders
    Shaker A. Mousa
    CNS Drugs, 2000, 13 : 155 - 160
  • [47] Radiological Experience Needed When Assessing PET/CT Imaging
    Liu, W.
    Liang, W.
    THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (05): : 317 - 317
  • [48] Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders
    Sandip Basu
    Babak Saboury
    Tom Werner
    Abass Alavi
    Molecular Imaging and Biology, 2011, 13 : 1051 - 1060
  • [49] Application of PET/CT and PET/MRI for evaluation of non-malignant disorders of the abdomen
    Bural, Gonca
    Alavi, Abass
    Torigian, Drew
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [50] Comparison of measurement between Xe/CT CBF and PET in cerebrovascular disease and brain tumor
    Nariai, T
    ACTA NEUROLOGICA SCANDINAVICA, 1996, 93 : 10 - &
12345